We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPolar Capital Regulatory News (POLR)

Share Price Information for Polar Capital (POLR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 526.00
Bid: 526.00
Ask: 527.00
Change: -3.00 (-0.57%)
Spread: 1.00 (0.19%)
Open: 530.00
High: 530.00
Low: 524.00
Prev. Close: 529.00
POLR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AuM Update

15 Apr 2021 07:00

RNS Number : 5118V
Polar Capital Holdings PLC
15 April 2021
 

 

15 April 2021 Polar Capital Holdings plc

AuM Update

 

 

Polar Capital Holdings plc ("Polar Capital" or the "Group"), the specialist asset management group, today provides its regular quarterly update of its unaudited statement of its Assets under Management ("AuM") for the financial year to 31 March 2021.

 

Group AUM (unaudited)

 

Polar Capital reports that as at 31 March 2021 its AuM were £20.9bn compared to £12.2bn at the end of March 2020, an increase of 71% over the year. During the period, AuM increased by £8.7bn which comprised net subscriptions of £2.1bn, inflows from reported acquisitions of £1.7bn, offset by outflows from a previously reported fund closure of £0.3bn and an increase of £5.2bn related to market movement and fund performance.

 

AuM movement in twelve months to 31 March 2021

Long-only

funds

Alternative

funds

Total

AuM at 1 April 2020

£11,078m

£1,083m

£12,161m

Net subscriptions/(redemptions)

£2,130m

£(22)m

£2,108m

Reported acquisitions

£1,618m

£81m

£1,699m

Closure of fund

-

£(301)m

£(301)m

Market movement and performance

£5,023m

£173m

£5,196m

Total AuM at 31 March 2021

£19,849m

£1,014m

£20,863m

 

 

 

Gavin Rochussen, Chief Executive, commented:

 

"AuM increased by 10% over the quarter to 31 March and by 71% over the year from £12.2bn on 1 April 2020 to £20.9bn on 31 March 2021. The increase in AuM of £8.7bn comprised net inflows of £2.1bn, an increase of £1.7bn due to the arrival of the Phaeacian and Dalton teams, a reduction of £0.3bn due to a fund closure, and market movement and fund performance added £5.2bn.

 

"We are pleased to report a good finish to the financial year in terms of flow momentum with net inflows into 14 of our funds amounting to £643m in the quarter ended 31 March. The fact we have also increased our AuM to over £20bn, doubling the size of our business over three and a half years, is testament to our strategic focus of offering a diversified range of funds whilst maintaining a rigorous focus on performance and active management.

 

 

"It is also pleasing that the pipeline for flows into our Emerging Markets Stars range of funds, which have sustainability at the core of their processes, continues to remain strong as the funds approach their three-year track records at Polar Capital.

 

"Fund performance across our fund range in the current calendar year is resilient with 57% of our funds outperforming benchmark calendar year to date.

 

"On a three-year annualised basis, 78% of AuM has performed ahead of benchmark at the end of March.

 

"70% of AuM in our UCITS fund range is ranked in the first quartile against peers in the Lipper universe over three years.

 

"The integration of the Dalton business onto the Polar Capital platform continues according to schedule and is anticipated to be completed by our financial half-year end.

 

"We remain confident that with our diverse range of funds and focus on performance in our actively managed complementary funds we are positioned to continue to perform well for our clients and will continue to generate net inflows. The net inflow momentum of the last quarter has continued into the first two weeks of April."

 

Polar Capital aims to announce its results for the financial year to 31 March 2021 on 1 July 2021.

 

 

For further information please contact:

 

Polar Capital

Gavin Rochussen (Chief Executive)John Mansell (Executive Director)

Samir Ayub (Finance Director)

+44 (0)20 7227 2700

 

Numis Securities Limited - Nomad and Joint Broker

Charles Farquhar

Stephen Westgate

Kevin Cruickshank (QE)

 

+44 (0)20 7260 1000

 

 

Peel Hunt LLP - Joint Broker

Andrew Buchanan

Rishi Shah

 

+44 (0)20 3597 8680

 

Camarco

Ed Gascoigne-Pees

Jennifer Renwick

Monique Perks

 

+44 (0)20 3757 4995

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAXLLFFFFEFA
Date   Source Headline
26th Apr 202410:33 amRNSForm 8.3 - RENALYTIX PLC
17th Apr 20243:55 pmRNSDirector/PDMR Shareholding
12th Apr 20245:43 pmRNSHolding(s) in Company
11th Apr 20247:00 amRNSAuM Update
9th Apr 20244:01 pmRNSChange of Company Secretary
15th Mar 20243:02 pmRNSForm 8.3 - Renalytix PLC
15th Mar 202410:23 amRNSForm 8.3 - Renalytix PLC - Replacement
13th Mar 20246:14 pmRNSForm 8.3 - RENALYTIX PLC
7th Mar 20244:30 pmRNSHolding(s) in Company
6th Mar 20245:47 pmRNSForm 8.3 - DIRECT LINE INSURANCE GROUP PLC
6th Mar 20245:37 pmRNSForm 8.3 - RENALYTIX PLC
27th Feb 20242:19 pmRNSForm 8.3 - Wincanton PLC
7th Feb 20242:09 pmRNSDirector/PDMR Shareholding
1st Feb 20247:00 amRNSBlock listing Interim Review
25th Jan 20244:53 pmRNSForm 8.3 -Wincanton PLC
11th Jan 20247:00 amRNSAuM Update
10th Jan 20242:54 pmRNSHolding(s) in Company
10th Jan 20242:51 pmRNSHolding(s) in Company
20th Nov 20237:00 amRNSPolar Capital Holdings Unaudited interim results
9th Nov 20237:00 amRNSInvestor Presentation covering Interim Results
26th Oct 20237:00 amRNSNotice of Interim Results
12th Oct 20237:00 amRNSAuM Update
28th Sep 20235:36 pmRNSResult of AGM
18th Aug 20234:45 pmRNSDirector/PDMR Shareholding
1st Aug 202312:05 pmRNSBlock listing Interim Review
19th Jul 20234:34 pmRNSDirector/PDMR Shareholding
18th Jul 20234:30 pmRNSDirector/PDMR Shareholding
13th Jul 202311:01 amRNSDirector/PDMR Shareholding - Replacement
13th Jul 202310:48 amRNSDirector/PDMR Shareholding
13th Jul 202310:31 amRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAuM Update
26th Jun 20233:34 pmRNSInvestor Presentation covering Full Year Results
26th Jun 20237:00 amRNSGroup Audited Results for year ended 31 March 2023
1st Jun 20237:00 amRNSTotal Voting Rights
25th May 202312:26 pmRNSIssue of Equity
10th May 20233:10 pmRNSDirector/PDMR Shareholding
21st Apr 20232:36 pmRNSHolding(s) in Company
14th Apr 20234:01 pmRNSDirector/PDMR Shareholding
13th Apr 20237:00 amRNSAuM Update
31st Mar 202312:23 pmRNSDirector/PDMR Shareholding
10th Mar 20233:17 pmRNSDirector/PDMR Shareholding
24th Feb 20235:18 pmRNSForm 8.3 - REDX Pharma PLC
16th Feb 20235:06 pmRNSDirector/PDMR Shareholding
7th Feb 202311:09 amRNSHolding(s) in Company
1st Feb 20237:00 amRNSBlock listing Interim Review
12th Jan 20237:00 amRNSAuM Update
30th Dec 20227:00 amRNSDirectorate Change
21st Nov 20227:00 amRNSUnaudited interim results
15th Nov 20227:00 amRNSInvestor Presentation covering Interim Results
24th Oct 20227:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.